Facial fillers for hiv
Dr. Scott W. Mosser, a San Francisco Board-Certified Plastic Surgeon reflects on options for facial fillers to treat HIV+ associated facial lipoatrophy (facial.
3 Aug After an expedited review, the Food and Drug Administration (FDA) today approved an injectable filler to correct facial fat loss in people with.
Filler agents are frequently used for treatment of HIV FLA to provide improvement in facial volume. There are limited published data on different filler options for.
Description:Food and Drug Administration FDA —approved facial wasting lipoatrophy treatments for Medicare beneficiaries who have facial lipoatrophy caused by antiretroviral drug use. Effective immediately, CMS will begin covering the cost of facial fillers for people living with HIV who are experiencing symptoms of depression related to the stigmatizing effects of lipoatrophy. Lipoatrophy is a condition where fat just beneath the skin is lost over time. Lipoatrophy is a side effect caused primarily by the antiretroviral drugs Zerit stavudine and Retrovir zidovudine. Though lipoatrophy can affect any part of the body, it is particularly noticeable and most often stigmatizing when it involves the face.